Evaluation of the Levels of Pain, Discomfort, and Functional Impairment With Two Techniques of Retraction

NCT05652244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-12-15

No results posted yet for this study

Summary

Thirty-eight patients requiring extraction of maxillary first premolars will participate in the study. They will be divided randomly into two groups: an en-masse retraction group and a two-step group. In each group, anterior teeth retraction will be initiated after completion of the leveling and alignment phase via closed nickel-titanium coil springs applying 150 g of force per side, Mini-implants will be used as an anchor unit in the en-masse retraction group, and TPA in the two-step's retraction group.

The levels of pain, discomfort, and functional impairments will be self-reported using a validated questionnaire with a 4-points Likert scale.

Conditions

  • Class II Malocclusion

Interventions

DEVICE

Mini-implants

En masse retraction of upper anterior teeth will be applied where mini-implants will be used as an anchor unit. Anterior teeth retraction will be initiated after completion of the leveling and alignment phase via closed nickel-titanium coil springs applying 150 g of force per side.

DEVICE

Transpalatal arche (TPA)

Two-step retraction of upper anterior teeth will be applied where transpalatal arches (TPAs) will be used as an anchor unit. Teeth retraction will be initiated after completion of the leveling and alignment phase via closed nickel-titanium coil springs applying 150 g of force per side.

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Salma Al-Sibaie, DDS,MSc · Department of Orthodontics, University of Al-Baath Dental School, Hamah, Syria

  • Mudar Mohammad Mousa, DDS · Department of orthodontics, Damascus University, Syria

  • Mohammad Y. Hajeer, DDS,MSc,PhD · Department of orthodontics, Damascus University, Syria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-13
Primary Completion
2014-05-03
Completion
2015-01-24

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05652244 on ClinicalTrials.gov